Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy

Red blood cells (RBCs) have recently emerged as promosing candidates for cancer treatment in terms of relieving tumor hypoxia and inducing oxidative damage against cancer cells, but they are still far from satisfactory due to their limited oxygen transport and reactive oxygen species generation rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiong, Wang, Sijia, Lin, Xinyi, Cao, Yanbing, Cai, Zhixiong, Wang, Jing, Zhang, Zhenxi, Liu, Xiaolong, Wu, Ming, Yao, Cuiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817004/
https://www.ncbi.nlm.nih.gov/pubmed/35122163
http://dx.doi.org/10.1007/s40820-022-00801-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817004/
https://www.ncbi.nlm.nih.gov/pubmed/35122163
http://dx.doi.org/10.1007/s40820-022-00801-z

Ejemplares similares